About Us

Peace of mind with iPSCs

Happier, healthier life with iPSC technology

The goal of I Peace is to alleviate the suffering of disease patients as quickly as possible, and help healthy people achieve a higher quality of life. Our motivation is deeply heartfelt. We at I Peace think carefully every day and night what steps we can take to achieve that future, now.

We have successfully developed a variety of innovative technologies related to iPSCs but we know we are not done yet. We are continuously working to make our technology user-friendly, to solve any barriers to application and to connect that with making lives happier. We have high ambitions but our feet are planted firmly in the ground to deliver our promise. We are forging our way forward to make iPSC technology accessible and widely implemented in society.

Currently, a growing amount of clinical research is being conducted with iPSCs, but manufacturing iPSCs is time and cost-intensive, making mass production difficult. The number of clinical-grade iPSC lines that are accessible currently is not enough to support this growth, and it is especially difficult for iPSC-based personalized medicine. I Peace will continue to realize mass production and cost reduction of clinical iPSCs.

Our Strength

Mass production of high quality iPSCs with innovative automated cell induction and culture technology

The production of iPSCs and various other types of clinical-grade cells requires a great deal of effort, and consequentially the production cost is extremely high. With the conventional methodology, it is difficult to produce a large number of clinical-grade cell lines, and manufacturing personalized cells for individuals at scale is next to impossible. Through our platform technology, we will enable mass production and price reduction of cells for clinical use. How can we achieve this? I Peace has successfully developed a technology that simplifies the process of generating iPSCs using high-level biotechnology and automates the process of preparing iPS cells using advanced robotics and fluidics technology. Furthermore, we have developed an automation system for clinical-grade cell production, and are working to further improve production efficiency and reduce costs. We have constructed a cell manufacturing facility licensed to manufacture cell products, and our clinical cell culture specialists are working to manufacture clinical-grade cells.

TEAM

Board Members

IPE_Dr.Tanabe

Koji Tanabe, Ph.D.

Founder & CEO

2006-2013 Shinya Yamanaka Lab., Graduate School of Medicine, Kyoto University
2013 Ph.D. in Medical Science, Shinya Yamanaka Laboratory, Graduate School of Medicine, Kyoto University (iPS Cell Research Institute)
2013-2017 Postdoctoral Fellow, Stanford University School of Medicine Institute for Stem Cell Biology and Regenerative Medicine Marius Wernig Laboratory
2015-2017 JSPS Research Fellow 2017-2019 Visiting Researcher, Stanford University School of Medicine Stem Cell Biology and Regenerative Medicine Institute

Koji has been involved in iPSC research since the beginning of iPSC development, and is the second author of a paper reporting the successful establishment of human iPS cells for the first time in the world. He researched the mechanism of reprogramming for 7 years at Dr. Shinya Yamanaka’s lab. As a postdoctoral researcher at the laboratory of Dr. Marius Wening of Stanford University, who succeeded in the world’s first direct reprogramming of skin cells to neurons, his work focused on the mechanism of direct reprogramming from blood cells to neurons and iPSC reprogramming. He has contributed to numerous iPSC papers and papers on direct reprogramming to neurons.

Scientific Advisory Board

IPE_Dr.Tanabe

Koji Tanabe, Ph.D.​

Founder & CEO

2006-2013 Shinya Yamanaka Lab., Graduate School of Medicine, Kyoto University
2013 Ph.D. in Medical Science, Shinya Yamanaka Laboratory, Graduate School of Medicine, Kyoto University (iPS Cell Research Institute)
2013-2017 Postdoctoral Fellow, Stanford University School of Medicine Institute for Stem Cell Biology and Regenerative Medicine Marius Wernig Laboratory
2015-2017 JSPS Research Fellow 2017-2019 Visiting Researcher, Stanford University School of Medicine Stem Cell Biology and Regenerative Medicine Institute

Koji has been involved in iPSC research since the beginning of iPSC development, and is the second author of a paper reporting the successful establishment of human iPS cells for the first time in the world. He researched the mechanism of reprogramming for 7 years at Dr. Shinya Yamanaka’s lab. As a postdoctoral researcher at the laboratory of Dr. Marius Wening of Stanford University, who succeeded in the world’s first direct reprogramming of skin cells to neurons, his work focused on the mechanism of direct reprogramming from blood cells to neurons and iPSC reprogramming. He has contributed to numerous iPSC papers and papers on direct reprogramming to neurons.

Kazutoshi Takahashi

Ph.D.

Associate Professor, iPS Cell Research Institute, Kyoto University / Visiting Researcher, Gladstone Research Institute

2005 Ph.D., Graduate School of Bioscience, Nara Institute of Science and Technology
2004-2006 JSPS Research Fellow 2006-2008 Kyoto University Research Institute of Regenerative Medicine
2008-2009 Assistant Professor, iPS Cell Research Center, Kyoto University
2009 Lecturer, Kyoto University, Center for Integrated Material-Cell Systems, iPS Cell Research Center
2010 Lecturer, iPS Cell Research Institute, Kyoto University
2015-Present J. David Gladstone Institute of Cardiovascular Desease Visiting Scientist (2016-2017 Staff Research Investigator)
2019-Present Kyoto University iPS Cell Research Institute Associate Professor

Dr. Takahashi has engaged in research as the right arm of Professor Shinya Yamanaka (who won the Nobel Prize for iPSCs). He has also won international awards, including the New York Stem Cell Foundation’s Robertson Stem Cell Prize for his work on cells.

Marius Wernig

M.D., Ph.D.

Professor of Pathology and Co-Director of the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University

2000 M.D./Ph.D. from the Technical University of Munich
2000-2003 Residency at the University of Bonn
2003-2008 Postdoctoral Fellow at the MIT Whitehead Institute
2008– Stanford University School of Medicine Stem Cell Biology and Regenerative Medicine Institute

Dr. Wernig’s laboratory specializes in the study of pluripotent stem cell biology and neurons, and was the first in the world successfully generate direct reprogrammed functional neuronal cells from skin fibroblasts. He has received a number of awards such as New York Stem Cell Foundation’s Robertson Stem Cell Prize and the Ogawa-Yamanaka Stem Cell Prize.

Mahendra Rao

M.D., Ph.D.

Chief Executive Officer at panCELLa

1983 M.D., Bombay University (current University of Mumbai)
1991 Ph.D. in Occurrence Neurobiology at California Institute of Technology
1990-1993 Doctoral Researcher, Case Western Reserve University
1994-2000 Associate Professor, the University of Utah Neurobiology
2006-2011 VP of Regenerative Medicine, Thermo Fisher Scientific (current Life Technologies)
2011-2014 Director, NIH Center for For Regenerative Medicine
2014– Founder and CSO at Mahendra Rao LLC / Chief Executive Officer at panCELLa

Dr. Rao is an internationally notable researcher in embryonic stem cells. He has a wealth of experience not only in research and education, but also in business serving as an advisor or a board member of many pharmaceutical / biotech companies, including as a co-founder of Q Therapeutics.

I Peace members

With highly experienced iPSC researchers at the center, the I Peace team includes a diverse mix of Japanese and US talent, including clinical cell culture specialists, cell processing facility technicians, robotics technicians, engineers, ex-investment bankers, etc. Together, we are continuously working to realize our vision as soon as possible.

Company Information

Company Name
I Peace, Inc.

Location Headquarter:Palo Alto, California, USAJapan subsidiary (I Peace, Ltd.) : Kyoto, Kyoto PrefectureJapan manufacturing site:Kyoto, Japan

Founder&CEO Koji Tanabe

Location_Palo Alto

I Peace headquarter
Palo Alto, California, USA

Mask Group

Japan Corporate/manufacturing facilities Japan, Kyoto Prefecture

Contact Us

We would love to hear from you!

We normally respond within 3 business days.